Medroxyprogesterone Acetate
- Product NDC
- 53002-3570
- 11-digit product format
- 530023570
- Labeler code
- 53002
- Product ID
- 53002-3570_ee170f0d-4dd7-4e01-bf75-848337c6fc66
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Medroxyprogesterone Acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA040159
- Marketing category
- ANDA
- Marketing start
- 1996-12-04
- Marketing end
- 0000-00-00
- Substance
- MEDROXYPROGESTERONE ACETATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Progesterone Congeners [CS],Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-3570-1 | Medroxyprogesterone Acetate | 10 in 1 BOTTLE | TABLET | 10 | | 6 |
| 53002-3570-3 | Medroxyprogesterone Acetate | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-3570 | MEDROXYPROGESTERONE ACETATE TABLET [RPK PHARMACEUTICALS, INC.] | 6 | Legacy NDC, 2 package rows | 20230609_ceccfb43-ad89-482d-9564-5867df1c936f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-3570-1 | 53002357001 | 10 TABLET in 1 BOTTLE (53002-3570-1) | 10 tablet | 2018-10-02 | 0000-00-00 | No | No | Current |
| 53002-3570-3 | 53002357003 | 30 TABLET in 1 BOTTLE (53002-3570-3) | 30 tablet | 2018-10-02 | 0000-00-00 | No | No | Current |